Could a hormone often feared by women actually reduce breast cancer risk? Join Dr. Hillary Lin, a Stanford-trained longevity physician with genetic risk herself, as she debunks myths, spotlights 2025 research, and reframes HRT from villain to potential health ally.What You'll Learn:• Insight into how estrogen and progesterone influence breast cancer—and why not all hormones are created equal• A re-examination of the Women’s Health Initiative (WHI) findings, in context of age, timing, and hormone types• Highlights from the E3N French study on natural (micronized) progesterone vs. synthetic progestins• Absolute vs. relative risk explained—why HRT’s impact is often overstated• The longevity case for HRT: bones, heart, brain, and healthspan benefits when started at “the window of opportunity”• Real patient stories—including Dr. Lin’s own experience and how she counsels women with elevated cancer risk• Critical caveats for breast cancer survivors and where non-hormonal alternatives come inChapters

00:00 Why Hormone Therapy Matters02:07 Understanding Estrogen and Progesterone05:22 The Women’s Health Initiative Legacy10:11 Natural vs Synthetic Progesterone15:15 Putting Breast Cancer Risk in Perspective18:38 Real Stories and Patient Choices26:32 For Women With Prior Breast Cancer28:03 What the Science Really Says31:16 Practical Takeaways for Women Considering HRT#HormoneTherapy #BreastCancer #LongevityMedicine #WomensHealth #HRTMyths #EstrogenFacts #HillaryLinMD #DrHillaryLin